Notice Type
Departmental
Notice Title

Notice of Application to Vary the Conditions of a Registered Trade Name Product (Notice No. MPI 817)

Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following variation application has been made to a registered trade name product under section 9(2) of the Act:

Trade Name: Profender

Reference: A009546-13

Active Ingredients and Concentrations:

Emodepside 21.4g/L
Praziquantel 85.8g/L

Formulation Type: Oily suspension/solution

Current Claim:

For the treatment and control of internal parasites in cats including:

    • Roundworms – mature, immature, and larval (L3 and L4) stages of Toxocara cati and mature, immature, larval (L4) stages of Toxascaris leonina
    • Hookworm Uncinaria stenocephala*, including larval (L4) and immature stages
    • Tapeworms – mature and immature stages of Dipylidium caninum, Taenia taeniaeformis.

Proposed New Claim:

For the treatment and control of internal parasites in cats including:

    • Roundworms – mature, immature, and larval (L3 and L4) stages of Toxocara cati, Toxocara cati (L3 larvae)-treatment of queens during late pregnancy to prevent lactogenic transmission to the offspring and mature, immature, larval (L4) stages of Toxascaris leonina
    • Hookworm Uncinaria stenocephala*, including larval (L4) and immature stages
    • Tapeworms – mature and immature stages of Dipylidium caninum, Taenia taeniaeformis
    • Lungworm – Aelurostrongylus abstrusus.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

  1. must state in full the reasons for making the submission; and
  2. may state any decision sought on that application; and
  3. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

  1. where submissions on this application are to be sent; and
  2. where requests for copies of the public information relating to the application can be sent; and
  3. where public information relating to the application can be viewed; and
  4. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:

Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland 0627. Postal Address: PO Box 2825, Shortland Street, Auckland 1140.

Dated at Wellington this 5th day of September 2017.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).